Cerus Corporation (CERS)
USD 1.29
(-7.86%)
USD 1.29
(-7.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -30.05 Million USD | -66.53% |
| 2022 | -34.08 Million USD | 30.36% |
| 2021 | -48.93 Million USD | 16.11% |
| 2020 | -58.33 Million USD | 11.92% |
| 2019 | -66.22 Million USD | -20.44% |
| 2018 | -54.98 Million USD | 4.42% |
| 2017 | -57.53 Million USD | 6.37% |
| 2016 | -61.44 Million USD | -0.61% |
| 2015 | -61.07 Million USD | -37.71% |
| 2014 | -44.34 Million USD | -56.72% |
| 2013 | -28.29 Million USD | -63.58% |
| 2012 | -17.3 Million USD | -8.64% |
| 2011 | -15.92 Million USD | 0.21% |
| 2010 | -15.95 Million USD | 33.04% |
| 2009 | -23.83 Million USD | 21.94% |
| 2008 | -30.53 Million USD | 29.27% |
| 2007 | -43.16 Million USD | -355.34% |
| 2006 | -9.48 Million USD | -1.49% |
| 2005 | -9.34 Million USD | 65.18% |
| 2004 | -26.82 Million USD | 50.17% |
| 2003 | -53.83 Million USD | 9.18% |
| 2002 | -59.27 Million USD | -10.02% |
| 2001 | -53.87 Million USD | -34.25% |
| 2000 | -40.13 Million USD | -61.18% |
| 1999 | -24.9 Million USD | 18.89% |
| 1998 | -30.7 Million USD | -93.08% |
| 1997 | -15.9 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -13 Million USD | -132.39% |
| 2024 Q3 | -961 Thousand USD | 89.64% |
| 2024 Q2 | -9.27 Million USD | 28.7% |
| 2023 Q4 | -5.59 Million USD | -6.77% |
| 2023 Q1 | -14.14 Million USD | -42.16% |
| 2023 FY | -56.75 Million USD | -66.53% |
| 2023 Q2 | -11.64 Million USD | 17.72% |
| 2023 Q3 | -5.24 Million USD | 54.96% |
| 2022 Q4 | -9.95 Million USD | -33.62% |
| 2022 FY | -34.08 Million USD | 30.36% |
| 2022 Q2 | -6.83 Million USD | 30.6% |
| 2022 Q3 | -7.44 Million USD | -8.95% |
| 2022 Q1 | -9.84 Million USD | -41.45% |
| 2021 Q2 | -14.4 Million USD | 12.44% |
| 2021 FY | -48.93 Million USD | 16.11% |
| 2021 Q4 | -6.96 Million USD | 37.43% |
| 2021 Q3 | -11.12 Million USD | 22.74% |
| 2021 Q1 | -16.44 Million USD | -14.69% |
| 2020 Q4 | -14.34 Million USD | -2.57% |
| 2020 Q2 | -14.6 Million USD | 5.16% |
| 2020 Q3 | -13.98 Million USD | 4.29% |
| 2020 FY | -58.33 Million USD | 11.92% |
| 2020 Q1 | -15.4 Million USD | 6.13% |
| 2019 Q4 | -16.4 Million USD | 3.25% |
| 2019 Q1 | -16.06 Million USD | -3.95% |
| 2019 FY | -66.22 Million USD | -20.44% |
| 2019 Q2 | -16.79 Million USD | -4.51% |
| 2019 Q3 | -16.95 Million USD | -0.98% |
| 2018 Q3 | -13.6 Million USD | -8.22% |
| 2018 Q2 | -12.57 Million USD | 5.87% |
| 2018 Q4 | -15.45 Million USD | -13.63% |
| 2018 Q1 | -13.35 Million USD | -23.08% |
| 2018 FY | -54.98 Million USD | 4.42% |
| 2017 Q2 | -16.2 Million USD | 10.44% |
| 2017 Q1 | -18.09 Million USD | -19.79% |
| 2017 Q3 | -12.38 Million USD | 23.59% |
| 2017 Q4 | -10.85 Million USD | 12.36% |
| 2017 FY | -57.53 Million USD | 6.37% |
| 2016 Q1 | -15.34 Million USD | -2.35% |
| 2016 Q2 | -16.73 Million USD | -9.08% |
| 2016 Q3 | -14.25 Million USD | 14.82% |
| 2016 Q4 | -15.1 Million USD | -5.93% |
| 2016 FY | -61.44 Million USD | -0.61% |
| 2015 FY | -61.07 Million USD | -37.71% |
| 2015 Q4 | -14.99 Million USD | 7.37% |
| 2015 Q3 | -16.18 Million USD | -4.26% |
| 2015 Q2 | -15.52 Million USD | -8.03% |
| 2015 Q1 | -14.37 Million USD | -12.49% |
| 2014 Q3 | -11.35 Million USD | -3.15% |
| 2014 Q1 | -9.21 Million USD | -18.1% |
| 2014 FY | -44.34 Million USD | -56.72% |
| 2014 Q4 | -12.77 Million USD | -12.55% |
| 2014 Q2 | -11 Million USD | -19.36% |
| 2013 Q1 | -4.96 Million USD | -37.85% |
| 2013 Q4 | -7.8 Million USD | 7.35% |
| 2013 Q3 | -8.42 Million USD | -18.53% |
| 2013 Q2 | -7.1 Million USD | -43.31% |
| 2013 FY | -28.29 Million USD | -63.58% |
| 2012 FY | -17.3 Million USD | -8.64% |
| 2012 Q4 | -3.59 Million USD | 16.92% |
| 2012 Q3 | -4.33 Million USD | 9.75% |
| 2012 Q2 | -4.79 Million USD | -4.97% |
| 2012 Q1 | -4.57 Million USD | -27.39% |
| 2011 Q2 | -5.47 Million USD | -30.03% |
| 2011 Q3 | -2.64 Million USD | 51.69% |
| 2011 Q4 | -3.58 Million USD | -35.64% |
| 2011 FY | -15.92 Million USD | 0.21% |
| 2011 Q1 | -4.21 Million USD | 11.33% |
| 2010 FY | -15.95 Million USD | 33.04% |
| 2010 Q2 | -3.54 Million USD | 10.34% |
| 2010 Q1 | -3.95 Million USD | 19.46% |
| 2010 Q4 | -4.75 Million USD | -28.24% |
| 2010 Q3 | -3.7 Million USD | -4.43% |
| 2009 Q1 | -7.43 Million USD | -3.74% |
| 2009 Q3 | -6.01 Million USD | -9.79% |
| 2009 Q2 | -5.47 Million USD | 26.3% |
| 2009 Q4 | -4.91 Million USD | 18.31% |
| 2009 FY | -23.83 Million USD | 21.94% |
| 2008 Q3 | -7.58 Million USD | 17.2% |
| 2008 FY | -30.53 Million USD | 29.27% |
| 2008 Q4 | -7.16 Million USD | 5.51% |
| 2008 Q2 | -9.15 Million USD | -38.1% |
| 2008 Q1 | -6.63 Million USD | -12.87% |
| 2007 Q3 | -10.48 Million USD | 44.56% |
| 2007 Q1 | -7.89 Million USD | -468.11% |
| 2007 Q4 | -5.87 Million USD | 43.98% |
| 2007 FY | -43.16 Million USD | -355.34% |
| 2007 Q2 | -18.91 Million USD | -139.5% |
| 2006 FY | -9.48 Million USD | -1.49% |
| 2006 Q3 | -2.7 Million USD | 54.51% |
| 2006 Q4 | 2.14 Million USD | 179.39% |
| 2006 Q1 | -2.98 Million USD | 10.9% |
| 2006 Q2 | -5.94 Million USD | -99.13% |
| 2005 Q1 | -1.06 Million USD | 75.64% |
| 2005 Q2 | -3.01 Million USD | -182.23% |
| 2005 Q3 | -1.9 Million USD | 36.79% |
| 2005 FY | -9.34 Million USD | 65.18% |
| 2005 Q4 | -3.34 Million USD | -75.56% |
| 2004 Q1 | -8.06 Million USD | 10.63% |
| 2004 Q2 | -10.33 Million USD | -28.2% |
| 2004 Q3 | -4.03 Million USD | 60.96% |
| 2004 Q4 | -4.38 Million USD | -8.72% |
| 2004 FY | -26.82 Million USD | 50.17% |
| 2003 Q3 | -13.11 Million USD | 15.75% |
| 2003 Q2 | -15.57 Million USD | 3.41% |
| 2003 Q4 | -9.02 Million USD | 31.22% |
| 2003 Q1 | -16.12 Million USD | 0.01% |
| 2003 FY | -53.83 Million USD | 9.18% |
| 2002 Q3 | -17.07 Million USD | -43.99% |
| 2002 Q1 | -14.22 Million USD | 1.36% |
| 2002 FY | -59.27 Million USD | -10.02% |
| 2002 Q2 | -11.85 Million USD | 16.6% |
| 2002 Q4 | -16.12 Million USD | 5.59% |
| 2001 Q2 | -13.18 Million USD | -7.61% |
| 2001 FY | -53.87 Million USD | -34.25% |
| 2001 Q4 | -14.41 Million USD | -2.8% |
| 2001 Q3 | -14.02 Million USD | -6.36% |
| 2001 Q1 | -12.25 Million USD | 1.44% |
| 2000 FY | -40.13 Million USD | -61.18% |
| 2000 Q1 | -8.18 Million USD | -7.67% |
| 2000 Q4 | -12.43 Million USD | -21.41% |
| 2000 Q3 | -10.24 Million USD | -10.37% |
| 2000 Q2 | -9.27 Million USD | -13.38% |
| 1999 Q3 | -6.2 Million USD | 1.59% |
| 1999 Q1 | -4.8 Million USD | 25.0% |
| 1999 FY | -24.9 Million USD | 18.89% |
| 1999 Q4 | -7.6 Million USD | -22.58% |
| 1999 Q2 | -6.3 Million USD | -31.25% |
| 1998 Q2 | -14 Million USD | -258.97% |
| 1998 Q1 | -3.9 Million USD | 17.02% |
| 1998 FY | -30.7 Million USD | -93.08% |
| 1998 Q3 | -6.4 Million USD | 54.29% |
| 1998 Q4 | -6.4 Million USD | 0.0% |
| 1997 Q3 | -2.2 Million USD | 52.17% |
| 1997 Q2 | -4.6 Million USD | -4.55% |
| 1997 FY | -15.9 Million USD | 0.0% |
| 1997 Q1 | -4.4 Million USD | 0.0% |
| 1997 Q4 | -4.7 Million USD | -113.64% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -109.268% |
| OrthoPediatrics Corp. | -25.76 Million USD | -16.638% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -182.949% |
| Talis Biomedical Corporation | -66.81 Million USD | 55.021% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -73.757% |
| Inogen, Inc. | -109.38 Million USD | 72.526% |
| Spectral AI, Inc. | -12.98 Million USD | -131.462% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 51.984% |
| CVRx, Inc. | -43.1 Million USD | 30.276% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -751.842% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -141.817% |
| Orthofix Medical Inc. | -139.11 Million USD | 78.396% |
| Venus Concept Inc. | -28.3 Million USD | -6.161% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 44.375% |
| Bioventus Inc. | -81.72 Million USD | 63.227% |
| BrainsWay Ltd. | -4.92 Million USD | -509.965% |
| Envoy Medical, Inc. | -18.37 Million USD | -63.589% |
| electroCore, Inc. | -18.8 Million USD | -59.814% |
| IceCure Medical Ltd | -15.57 Million USD | -92.944% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 38.012% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -74.038% |
| MaxCyte, Inc. | -48.29 Million USD | 37.777% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -151.379% |
| Nexalin Technology, Inc. | -5.69 Million USD | -427.588% |
| PAVmed Inc | -68.79 Million USD | 56.315% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 46.868% |
| RxSight, Inc. | -50.08 Million USD | 39.996% |
| Sight Sciences, Inc. | -57.27 Million USD | 47.528% |
| SI-BONE, Inc. | -46.93 Million USD | 35.963% |
| TELA Bio, Inc. | -44.07 Million USD | 31.814% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 44.5% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 41.563% |
| LivaNova PLC | -68.49 Million USD | 56.126% |
| 908 Devices Inc. | -42.75 Million USD | 29.714% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 82.668% |
| Nemaura Medical Inc. | -9.59 Million USD | -213.208% |
| NeuroPace, Inc. | -27.17 Million USD | -10.595% |
| LENSAR, Inc. | -12.22 Million USD | -145.752% |
| Apyx Medical Corporation | -17.25 Million USD | -74.129% |
| Cutera, Inc. | -156.23 Million USD | 80.764% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -249.291% |
| BioSig Technologies, Inc. | -28.51 Million USD | -5.405% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 65.708% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -33.89% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 126.947% |
| Axonics, Inc. | -26.05 Million USD | -15.336% |
| Outset Medical, Inc. | -169.77 Million USD | 82.298% |
| IRIDEX Corporation | -10 Million USD | -200.32% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 72.471% |
| IRadimed Corporation | 20.03 Million USD | 249.999% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -264.5% |
| INVO Bioscience, Inc. | -6.76 Million USD | -344.101% |
| Telesis Bio, Inc. | -35.15 Million USD | 14.501% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 309.721% |
| Varex Imaging Corporation | 32.1 Million USD | 193.623% |
| Quipt Home Medical Corp. | 3.91 Million USD | 866.854% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -147.696% |
| Pulmonx Corporation | -61.93 Million USD | 51.477% |
| Dynatronics Corporation | -2.27 Million USD | -1222.145% |
| Modular Medical, Inc. | -17.52 Million USD | -71.447% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -105.294% |
| Semler Scientific, Inc. | 22.25 Million USD | 235.033% |
| InMode Ltd. | 195.66 Million USD | 115.36% |
| Bruker Corporation | 436.9 Million USD | 106.879% |
| Cytosorbents Corporation | -31.2 Million USD | 3.705% |
| DexCom, Inc. | 597.7 Million USD | 105.028% |
| Align Technology, Inc. | 643.33 Million USD | 104.671% |
| Viveve Medical, Inc. | -21.55 Million USD | -39.438% |
| ZimVie Inc. | -30.93 Million USD | 2.864% |
| Movano Inc. | -29.69 Million USD | -1.223% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -7.93% |
| Nexalin Technology, Inc. | -5.69 Million USD | -427.588% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -751.842% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 87.114% |
| Profound Medical Corp. | -28.61 Million USD | -5.022% |
| Insulet Corporation | 220 Million USD | 113.66% |
| enVVeno Medical Corporation | -25.23 Million USD | -19.078% |
| Surmodics, Inc. | -5.64 Million USD | -432.383% |
| iCAD, Inc. | -7.68 Million USD | -290.857% |
| Nuwellis, Inc. | -17.63 Million USD | -70.465% |
| Biotricity, Inc. | -8.82 Million USD | -240.418% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 75.989% |
| Aethlon Medical, Inc. | -12.63 Million USD | -137.826% |
| InspireMD, Inc. | -21.14 Million USD | -42.142% |
| PAVmed Inc. | -68.79 Million USD | 56.315% |
| BIOLASE, Inc. | -17.93 Million USD | -67.548% |
| Beyond Air, Inc. | -63 Million USD | 52.301% |
| FONAR Corporation | 16.53 Million USD | 281.75% |
| AxoGen, Inc. | -21.46 Million USD | -40.029% |
| Vivani Medical, Inc. | -26.96 Million USD | -11.452% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 266.582% |
| Inari Medical, Inc. | -14.03 Million USD | -114.175% |
| UFP Technologies, Inc. | 57.66 Million USD | 152.117% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -509.891% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -376.595% |
| Tenon Medical, Inc. | -15.72 Million USD | -91.092% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -302.101% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 29.629% |
| AdaptHealth Corp. | -598.4 Million USD | 94.978% |
| Sintx Technologies, Inc. | -13.35 Million USD | -124.981% |
| NanoVibronix, Inc. | -3.43 Million USD | -774.651% |
| Quanterix Corporation | -49.7 Million USD | 39.532% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -147.696% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -7767.277% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 91.015% |
| TransMedics Group, Inc. | -28.72 Million USD | -4.616% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -27.279% |
| NeuroMetrix, Inc. | -7.15 Million USD | -320.232% |
| Hyperfine, Inc. | -48.11 Million USD | 37.539% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 53.783% |
| Biomerica, Inc. | -6.36 Million USD | -372.012% |
| Bone Biologics Corporation | -9.42 Million USD | -218.753% |
| AVITA Medical, Inc. | -40.4 Million USD | 25.615% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -191.459% |
| Silk Road Medical, Inc | -59.27 Million USD | 49.296% |